You may qualify if:
- You are aged 18 years or older
- You have been diagnosed as having Fabry disease
The STAAR study has been designed to investigate the potential of an investigational gene therapy called ST-920 to treat men and women living with Fabry disease.
People who qualify will receive:
- Study-related medical care
- Reimbursement for travel
- All people who pass screening assessments and enter into the study will receive the study drug ST-920